Biogen Historical Financial Ratios

BIIB Stock

USD 142.36 1.46 1.04%

Biogen is presently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0022, PTB Ratio of 1.27 or Days Sales Outstanding of 76.42 will help investors to properly organize and evaluate Biogen Inc financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Biogen Financial Ratios Analysis

Biogen IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Biogen investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Biogen financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Biogen history.

Biogen Financial Ratios Chart

At present, Biogen's Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 120.47, whereas Price To Sales Ratio is forecasted to decline to 2.19.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding Operating Cash Flow Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Biogen Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Biogen sales, a figure that is much harder to manipulate than other Biogen Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Biogen Inc dividend as a percentage of Biogen stock price. Biogen Inc dividend yield is a measure of Biogen stock productivity, which can be interpreted as interest rate earned on an Biogen investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Most ratios from Biogen's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2024	2025 (projected)
Dividend Yield	0.00228	0.002166
Price To Sales Ratio	2.3	2.19

Dividend Yield Price To Sales Ratio

Biogen fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		0.99	0.91	-0.35	-0.56	-0.58	-0.51	-0.33	-0.29	0.91	1.0	-0.42	-0.94	-0.59	-0.47	0.8	0.84	0.12	-0.49	0.99	0.36	0.75	-0.38	-0.54	-0.51	-0.93
Dividend Yield	0.99		0.85	-0.32	-0.46	-0.48	-0.46	-0.27	-0.35	0.85	0.99	-0.36	-0.95	-0.58	-0.45	0.83	0.88	0.05	-0.45	0.97	0.27	0.8	-0.44	-0.51	-0.55	-0.92
Ptb Ratio	0.91	0.85		-0.52	-0.79	-0.72	-0.49	-0.5	-0.06	1.0	0.91	-0.48	-0.76	-0.52	-0.41	0.61	0.65	0.3	-0.55	0.9	0.61	0.52	-0.17	-0.56	-0.39	-0.86
Days Sales Outstanding	-0.35	-0.32	-0.52		0.59	0.2	0.13	0.53	-0.13	-0.52	-0.35	0.15	0.12	0.35	0.18	-0.33	-0.23	-0.25	0.36	-0.29	-0.49	-0.03	-0.02	0.44	0.01	0.26
Book Value Per Share	-0.56	-0.46	-0.79	0.59		0.65	0.44	0.61	-0.11	-0.79	-0.56	0.46	0.4	0.35	0.36	-0.23	-0.09	-0.32	0.55	-0.54	-0.67	-0.07	-0.01	0.39	-0.23	0.52
Free Cash Flow Yield	-0.58	-0.48	-0.72	0.2	0.65		0.78	0.42	-0.28	-0.72	-0.58	0.87	0.56	0.63	0.55	-0.45	-0.33	-0.54	0.53	-0.67	-0.54	-0.15	-0.27	0.41	0.16	0.6
Operating Cash Flow Per Share	-0.51	-0.46	-0.49	0.13	0.44	0.78		0.53	0.02	-0.49	-0.5	0.93	0.56	0.82	0.81	-0.65	-0.33	-0.21	0.59	-0.6	-0.4	-0.32	-0.02	0.21	0.01	0.52
Average Payables	-0.33	-0.27	-0.5	0.53	0.61	0.42	0.53		-0.15	-0.5	-0.33	0.53	0.12	0.37	0.51	-0.3	-0.1	-0.3	0.6	-0.32	-0.67	-0.32	-0.11	0.34	-0.1	0.3
Capex To Depreciation	-0.29	-0.35	-0.06	-0.13	-0.11	-0.28	0.02	-0.15		-0.06	-0.29	-0.32	0.35	0.1	0.01	-0.28	-0.39	0.91	-0.13	-0.26	0.17	-0.35	0.98	-0.55	0.25	0.31
Pb Ratio	0.91	0.85	1.0	-0.52	-0.79	-0.72	-0.49	-0.5	-0.06		0.91	-0.48	-0.76	-0.52	-0.41	0.61	0.65	0.3	-0.55	0.9	0.61	0.52	-0.17	-0.56	-0.39	-0.86
Ev To Sales	1.0	0.99	0.91	-0.35	-0.56	-0.58	-0.5	-0.33	-0.29	0.91		-0.42	-0.94	-0.59	-0.47	0.8	0.84	0.12	-0.49	0.99	0.36	0.75	-0.38	-0.54	-0.51	-0.93
Free Cash Flow Per Share	-0.42	-0.36	-0.48	0.15	0.46	0.87	0.93	0.53	-0.32	-0.48	-0.42		0.46	0.74	0.78	-0.54	-0.23	-0.53	0.61	-0.51	-0.42	-0.22	-0.35	0.4	-0.02	0.41
Roic	-0.94	-0.95	-0.76	0.12	0.4	0.56	0.56	0.12	0.35	-0.76	-0.94	0.46		0.64	0.52	-0.82	-0.81	-0.03	0.39	-0.95	-0.11	-0.72	0.41	0.42	0.48	0.88
Inventory Turnover	-0.59	-0.58	-0.52	0.35	0.35	0.63	0.82	0.37	0.1	-0.52	-0.59	0.74	0.64		0.82	-0.87	-0.56	-0.14	0.66	-0.63	-0.26	-0.35	0.1	0.31	0.24	0.5
Net Income Per Share	-0.47	-0.45	-0.41	0.18	0.36	0.55	0.81	0.51	0.01	-0.41	-0.47	0.78	0.52	0.82		-0.7	-0.33	-0.24	0.7	-0.5	-0.29	-0.41	-0.03	0.31	-0.02	0.28
Days Of Inventory On Hand	0.8	0.83	0.61	-0.33	-0.23	-0.45	-0.65	-0.3	-0.28	0.61	0.8	-0.54	-0.82	-0.87	-0.7		0.85	0.05	-0.6	0.8	0.18	0.7	-0.31	-0.44	-0.51	-0.69
Payables Turnover	0.84	0.88	0.65	-0.23	-0.09	-0.33	-0.33	-0.1	-0.39	0.65	0.84	-0.23	-0.81	-0.56	-0.33	0.85		-0.05	-0.32	0.83	0.12	0.77	-0.44	-0.38	-0.84	-0.79
Capex To Revenue	0.12	0.05	0.3	-0.25	-0.32	-0.54	-0.21	-0.3	0.91	0.3	0.12	-0.53	-0.03	-0.14	-0.24	0.05	-0.05		-0.35	0.13	0.31	-0.03	0.87	-0.77	0.04	-0.04
Cash Per Share	-0.49	-0.45	-0.55	0.36	0.55	0.53	0.59	0.6	-0.13	-0.55	-0.49	0.61	0.39	0.66	0.7	-0.6	-0.32	-0.35		-0.49	-0.61	-0.32	-0.1	0.45	0.02	0.37
Pocfratio	0.99	0.97	0.9	-0.29	-0.54	-0.67	-0.6	-0.32	-0.26	0.9	0.99	-0.51	-0.95	-0.63	-0.5	0.8	0.83	0.13	-0.49		0.38	0.71	-0.34	-0.5	-0.52	-0.95
Interest Coverage	0.36	0.27	0.61	-0.49	-0.67	-0.54	-0.4	-0.67	0.17	0.61	0.36	-0.42	-0.11	-0.26	-0.29	0.18	0.12	0.31	-0.61	0.38		0.07	0.12	-0.3	0.01	-0.37
Payout Ratio	0.75	0.8	0.52	-0.03	-0.07	-0.15	-0.32	-0.32	-0.35	0.52	0.75	-0.22	-0.72	-0.35	-0.41	0.7	0.77	-0.03	-0.32	0.71	0.07		-0.4	-0.43	-0.57	-0.67
Capex To Operating Cash Flow	-0.38	-0.44	-0.17	-0.02	-0.01	-0.27	-0.02	-0.11	0.98	-0.17	-0.38	-0.35	0.41	0.1	-0.03	-0.31	-0.44	0.87	-0.1	-0.34	0.12	-0.4		-0.43	0.28	0.4
Pfcf Ratio	-0.54	-0.51	-0.56	0.44	0.39	0.41	0.21	0.34	-0.55	-0.56	-0.54	0.4	0.42	0.31	0.31	-0.44	-0.38	-0.77	0.45	-0.5	-0.3	-0.43	-0.43		0.21	0.41
Days Payables Outstanding	-0.51	-0.55	-0.39	0.01	-0.23	0.16	0.01	-0.1	0.25	-0.39	-0.51	-0.02	0.48	0.24	-0.02	-0.51	-0.84	0.04	0.02	-0.52	0.01	-0.57	0.28	0.21		0.53
Income Quality	-0.93	-0.92	-0.86	0.26	0.52	0.6	0.52	0.3	0.31	-0.86	-0.93	0.41	0.88	0.5	0.28	-0.69	-0.79	-0.04	0.37	-0.95	-0.37	-0.67	0.4	0.41	0.53

Click cells to compare fundamentals

Biogen Account Relationship Matchups

High Positive Relationship

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Dividend Yield	+ 0.99	Price To Sales Ratio
Pocfratio	+ 0.99	Price To Sales Ratio
Ev To Sales	+ 0.99	Dividend Yield
Pocfratio	+ 0.99	Ev To Sales

High Negative Relationship

Income Quality	- 0.95	Pocfratio
Pocfratio	- 0.95	Roic
Roic	- 0.95	Dividend Yield
Roic	- 0.94	Ev To Sales
Roic	- 0.94	Price To Sales Ratio
Income Quality	- 0.93	Ev To Sales

Biogen fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	2.93	3.26	3.96	3.81	2.3	2.19
Ptb Ratio	3.69	3.26	3.01	2.53	1.33	1.27
Days Sales Outstanding	63.18	65.2	76.65	77.93	52.99	76.42
Book Value Per Share	66.41	73.51	92.14	102.28	114.73	120.47
Free Cash Flow Yield	0.12	0.0934	0.0935	0.0284	0.033	0.11
Operating Cash Flow Per Share	26.29	24.41	9.53	10.69	19.74	20.72
Stock Based Compensation To Revenue	0.0147	0.0217	0.025	0.0269	0.0301	0.0255
Capex To Depreciation	1.21	0.6	0.47	0.63	0.53	0.51
Pb Ratio	3.69	3.26	3.01	2.53	1.33	1.27
Ev To Sales	3.41	3.74	4.27	4.45	2.74	2.61
Free Cash Flow Per Share	22.86	22.43	7.85	8.54	17.27	18.13
Inventory Turnover	2.43	1.69	1.56	1.0	1.15	1.86
Net Income Per Share	24.86	10.44	20.97	8.02	11.2	11.76
Days Of Inventory On Hand	216.06	233.82	215.38	364.14	418.76	276.57
Payables Turnover	4.26	3.97	3.58	6.28	7.22	5.62
Research And Ddevelopement To Revenue	0.16	0.3	0.23	0.22	0.27	0.37
Capex To Revenue	0.041	0.0269	0.0239	0.0317	0.0372	0.0353
Cash Per Share	16.22	25.5	33.67	7.26	16.3	17.12
Pocfratio	9.31	9.83	29.07	24.2	7.75	7.36
Interest Coverage	20.45	11.2	9.41	8.49	9.77	9.28
Capex To Operating Cash Flow	0.0946	0.13	0.081	0.18	0.2	0.12
Pfcf Ratio	10.71	10.69	35.26	30.3	8.86	9.3
Days Payables Outstanding	91.98	101.94	78.74	58.11	66.82	63.48
Income Quality	1.04	2.11	0.47	1.33	1.76	1.51
Roe	0.37	0.14	0.23	0.0785	0.0976	0.096
Ev To Operating Cash Flow	10.85	11.3	31.37	28.27	9.23	8.77
Pe Ratio	9.85	22.99	13.21	32.25	13.65	12.97
Return On Tangible Assets	0.25	0.0979	0.18	0.0947	0.14	0.08
Ev To Free Cash Flow	12.48	12.29	38.06	35.39	10.55	11.08
Earnings Yield	0.1	0.0435	0.0757	0.031	0.0733	0.0769
Net Debt To E B I T D A	1.13	2.15	0.73	2.65	3.04	3.19
Current Ratio	1.84	1.83	2.99	2.0	1.35	1.28
Tangible Book Value Per Share	11.43	19.97	39.84	1.5	3.75	6.62
Receivables Turnover	5.78	5.6	4.76	4.68	6.89	12.39

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.063

Earnings Share

11.17

Revenue Per Share

66.455

Quarterly Revenue Growth

0.029

Return On Assets

0.0529

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Biogen Historical Financial Ratios

About Biogen Financial Ratios Analysis

Biogen Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Operating Cash Flow Per Share

Biogen fundamentals Correlations

Biogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biogen fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY